AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19
Author(s) -
Shruti Gupta,
Steven G. Coca,
Lili Chan,
Michal L. Melamed,
Samantha K. Brenner,
Salim S. Hayek,
Anne Sutherland,
Isha Puri,
Anand Srivastava,
Amanda K. LeonbergYoo,
Alexandre M. Shehata,
Jennifer E. Flythe,
Arash Rashidi,
Edward J. Schenck,
Nitender Goyal,
S. Susan Hedayati,
Rajany Dy,
Anip Bansal,
Ambarish M. Athavale,
H. Bryant Nguyen,
Anitha Vijayan,
David M. Charytan,
Carl E. Schulze,
Min J. Joo,
Allon N. Friedman,
Jingjing Zhang,
Marie Anne Sosa,
Eric Judd,
Juan Carlos Q. Velez,
Mary C. Mallappallil,
Roberta E. Redfern,
Amar D. Bansal,
Javier A. Neyra,
Kathleen D. Liu,
Amanda D. Renaghan,
Marta Christov,
Miklos Z. Molnar,
Shreyak Sharma,
Omer Kamal,
Benjamin G. Wu,
Samuel Short,
Andrew J. Admon,
Meghan E. Sise,
Wei Wang,
Chirag R. Parikh,
David E. Leaf
Publication year - 2020
Publication title -
journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.451
H-Index - 279
eISSN - 1533-3450
pISSN - 1046-6673
DOI - 10.1681/asn.2020060897
Subject(s) - renal replacement therapy , critically ill , covid-19 , medicine , intensive care medicine , nephrology , acute kidney injury , critical illness , urology , virology , disease , outbreak , infectious disease (medical specialty)
AKI is a common sequela of coronavirus disease 2019 (COVID-19). However, few studies have focused on AKI treated with RRT (AKI-RRT).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom